纵横研报
Ticker Detail

688566.SHG

¥27.2+1.30% 吉贝尔 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
Jiangsu Jibeier Pharmaceutical Co Ltd
医疗健康 · 专科与仿制药

Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the drug research and development and production in China. The company's products cover multiple therapeutic areas such as increasing white blood cells, fighting hypertension, enhancing immunity, treating joint diseases, fighting eye infections, treating bronchitis, protecting liver function, etc. It is also developing drugs for the treatment of depression, tumors, stomach and gastric diseases, and other diseases. In addition, the company offers its products in tablets, capsules, and eye drops forms. Jiangsu Jibeier Pharmaceutical Co., Ltd. was founded in 2001 and is based in Zhenjiang, China.

MARKET 市值 5.26B CNY PE 20.6x 52W ¥22.82 – ¥44.68 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY 12.2% ROE 10.5% 营业利润率 22.5% 净利润率 25.7%
ANALYST 股息率 2.06%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制